About Chugai
Chugai's mission is to create innovative drugs
for the benefit of patients.
News ReleasesRSS
- Jul 09, 2019 Further Clinical Data including Long-Term Follow-up for Chugai’s Hemlibra Presented at ISTH
- Jun 27, 2019 Chugai Obtains Approval of FoundationOne CDx Cancer Genomic Profile as a Companion Diagnostic for Rozlytrek
- Jun 18, 2019 Anti-Cancer Agent Rozlytrek, Approved for the Treatment of NTRK Fusion Gene Positive Advanced/Recurrent Solid Tumors
- Jun 14, 2019 Chugai and Mitsubishi Logistics Enter into Service Agreement for Logistics Operations
- Jun 03, 2019 Chugai Files for Additional Indication of ALK Inhibitor ALECENSA for Recurrent or Refractory ALK Fusion Gene-Positive Anaplastic Large Cell Lymphoma (ALCL)
-
Diversity and Inclusion Initiatives
Find information on our initiatives to promote work-life balance and diverse human resources, and performance data for topics such as the ratio of female employees.
-
Engagement with Employees
Chugai promotes engagement with employees by conducting talent management according to each person's capabilities and aptitude, providing systems that help our diverse people to succeed, and creating supportive work environments.
For more information
Feature: Chugai’s Sustainability Activities
Recent Social Contribution Activities
-
Biology Lab Classes for Children Held (2018)
-
Participating in the 48th Annual Cleaning of the Famed Nihonbashi Bridge
-
Chugai to Take Part in Relay for Life Japan 2018
